108 related articles for article (PubMed ID: 18610743)
1. Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells in vivo.
Palakurthi S; Wilson J; McQuarrie SA; Suresh MR; Mercer JR; Miller GG
In Vivo; 2008; 22(3):321-6. PubMed ID: 18610743
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma].
Zhao ZG; Ran YL; Zheng R; Kong J; Chen SZ; Yu L; Yang ZH
Ai Zheng; 2002 May; 21(5):460-3. PubMed ID: 12452032
[TBL] [Abstract][Full Text] [Related]
3. Modern trends in radioimmunotherapy of cancer: pretargeting strategies for the treatment of ovarian cancer.
McQuarrie SA; Xiao Z; Miller GG; Mercer JR; Suresh MR
Q J Nucl Med; 2001 Jun; 45(2):160-6. PubMed ID: 11476165
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of nanopharmaceuticals used in the radioimmunotherapy of ovarian cancer.
McQuarrie S; Mercer J; Syme A; Suresh M; Miller G
J Pharm Pharm Sci; 2005 Feb; 7(4):29-34. PubMed ID: 15850546
[TBL] [Abstract][Full Text] [Related]
6. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies.
Griffiths GL; Goldenberg DM; Knapp FF; Callahan AP; Chang CH; Hansen HJ
Cancer Res; 1991 Sep; 51(17):4594-602. PubMed ID: 1873804
[TBL] [Abstract][Full Text] [Related]
7. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes.
Pan H; Han L; Chen W; Yao M; Lu W
J Control Release; 2008 Feb; 125(3):228-35. PubMed ID: 18022270
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies.
Boerman O; Massuger L; Makkink K; Thomas C; Kenemans P; Poels L
Anticancer Res; 1990; 10(5A):1289-95. PubMed ID: 2241105
[TBL] [Abstract][Full Text] [Related]
9. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
10. Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model.
Gustafsson AM; Bäck T; Elgqvist J; Jacobsson L; Hultborn R; Albertsson P; Morgenstern A; Bruchertseifer F; Jensen H; Lindegren S
Nucl Med Biol; 2012 Jan; 39(1):15-22. PubMed ID: 21958859
[TBL] [Abstract][Full Text] [Related]
11. Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model.
Andersson H; Elgqvist J; Horvath G; Hultborn R; Jacobsson L; Jensen H; Karlsson B; Lindegren S; Palm S
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3914S-21S. PubMed ID: 14506189
[TBL] [Abstract][Full Text] [Related]
12. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
[TBL] [Abstract][Full Text] [Related]
13. A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitro.
Xiao Z; McQuarrie SA; Suresh MR; Mercer JR; Gupta S; Miller GG
J Biotechnol; 2002 Mar; 94(2):171-84. PubMed ID: 11796170
[TBL] [Abstract][Full Text] [Related]
14. The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels.
Shih LB; Thorpe SR; Griffiths GL; Diril H; Ong GL; Hansen HJ; Goldenberg DM; Mattes MJ
J Nucl Med; 1994 May; 35(5):899-908. PubMed ID: 8176479
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effect of nanospheres coupled with the anti-human liver cancer monoclonal antibody HAb18].
Kan HP; Liu ZJ; Tan YF; Lin YX; Li CF; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1503-5. PubMed ID: 18753092
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
[TBL] [Abstract][Full Text] [Related]
17. Investigations of directly labeling antibodies with rhenium-188.
Winnard P; Virzi E; Fogarasi M; Rusckowski M; Hnatowich DJ
Q J Nucl Med; 1996 Jun; 40(2):151-60. PubMed ID: 8909100
[TBL] [Abstract][Full Text] [Related]
18. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
[TBL] [Abstract][Full Text] [Related]
19. Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2.
Elgqvist J; Andersson H; Bernhardt P; Bäck T; Claesson I; Hultborn R; Jensen H; Johansson BR; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1228-37. PubMed ID: 17145538
[TBL] [Abstract][Full Text] [Related]
20. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
Gold DV; Goldenberg DM; Karacay H; Rossi EA; Chang CH; Cardillo TM; McBride WJ; Sharkey RM
Cancer Res; 2008 Jun; 68(12):4819-26. PubMed ID: 18559529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
